Clinical Trial Update: Kinectics of Distribution of Doxorubicin-Lipiodol Emulsion in c-TACE [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the distribution kinetics of a doxorubicin-lipiodol emulsion used in transarterial chemoembolization for hepatocellular carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• doxorubicin-lipiodol emulsion (doxorubicin-lipiodol emulsion)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Hepato Cellular Carcinoma | Phase 4 | Status: COMPLETED